{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:00:53Z","timestamp":1793397653883,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.eclinm.2024.102799","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T09:16:00Z","timestamp":1727082960000},"page":"102799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial"],"prefix":"10.1016","volume":"76","author":[{"given":"David","family":"Erritzoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2565-4628","authenticated-orcid":false,"given":"Tommaso","family":"Barba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7829-493X","authenticated-orcid":false,"given":"Kyle T.","family":"Greenway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonny","family":"Martell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Giribaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Timmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashleigh","family":"Murphy-Beiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Baker","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2989-2981","authenticated-orcid":false,"given":"Brandon","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Carhart-Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2024.102799_bib1","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2024.102799_bib2","first-page":"1517","article-title":"Depression is the leading cause of disability around the world","volume":"317","author":"Friedrich","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2024.102799_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.65","article-title":"Major depressive disorder","volume":"2","author":"Otte","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.eclinm.2024.102799_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/13651501.2020.1779308","article-title":"Relapse prevention in recurrent major depressive disorder. A comparison of different treatment options based on clinical experience and a critical review of the literature","volume":"24","author":"Cosci","year":"2020","journal-title":"Int J Psychiatry Clin Pract"},{"key":"10.1016\/j.eclinm.2024.102799_bib5","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2024.102799_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/10503307.2019.1566676","article-title":"The dose-response effect in routinely delivered psychological therapies: a systematic review","volume":"30","author":"Robinson","year":"2020","journal-title":"Psychother Res"},{"key":"10.1016\/j.eclinm.2024.102799_bib7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/17512433.2020.1772054","article-title":"Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments","volume":"13","author":"Greenway","year":"2020","journal-title":"Expet Rev Clin Pharmacol"},{"key":"10.1016\/j.eclinm.2024.102799_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1176\/appi.focus.12.3.347","article-title":"Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis","volume":"12","author":"Cuijpers","year":"2014","journal-title":"Focus"},{"key":"10.1016\/j.eclinm.2024.102799_bib9","first-page":"168","article-title":"Steps following attainment of remission: discontinuation of antidepressant therapy","volume":"3","author":"Shelton","year":"2001","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.eclinm.2024.102799_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4068\/cmj.2018.54.2.101","article-title":"Addressing the side effects of contemporary antidepressant drugs: a comprehensive review","volume":"54","author":"Wang","year":"2018","journal-title":"Chonnam Med J"},{"key":"10.1016\/j.eclinm.2024.102799_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1017\/S1461145702002870","article-title":"Emotional blunting associated with SSRI-induced sexual dysfunction. Do SSRIs inhibit emotional responses?","volume":"5","author":"Opbroek","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.eclinm.2024.102799_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2015.12.029","article-title":"Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: a systematic review","volume":"193","author":"Ho","year":"2016","journal-title":"J Affect Disord"},{"key":"10.1016\/j.eclinm.2024.102799_bib13","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/jamapsychiatry.2019.0268","article-title":"Effectiveness and acceptability of cognitive behaviour therapy delivery formats in adults with depression: a network meta-analysis","volume":"76","author":"Cuijpers","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.eclinm.2024.102799_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cpr.2015.05.001","article-title":"Dropout from individual psychotherapy for major depression: a meta-analysis of randomized clinical trials","volume":"40","author":"Cooper","year":"2015","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.eclinm.2024.102799_bib15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1037\/a0028226","article-title":"Premature discontinuation in adult psychotherapy: a meta-analysis","volume":"80","author":"Swift","year":"2012","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.eclinm.2024.102799_bib16","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2024.102799_bib17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.eclinm.2024.102799_bib18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.eclinm.2024.102799_bib19","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2024.102799_bib20","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2024.102799_bib21","doi-asserted-by":"crossref","first-page":"10544","DOI":"10.1523\/JNEUROSCI.3007-12.2013","article-title":"Activation of serotonin 2A receptors underlies the psilocybin-induced effects on \u03b1 oscillations, N170 visual-evoked potentials, and visual hallucinations","volume":"33","author":"Kometer","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.eclinm.2024.102799_bib22","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","article-title":"Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","volume":"44","author":"Madsen","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.eclinm.2024.102799_bib23","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/0269881119855974","article-title":"Emotional breakthrough and psychedelics: validation of the emotional breakthrough inventory","volume":"33","author":"Roseman","year":"2019","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.eclinm.2024.102799_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fnhum.2016.00269","article-title":"Ego-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI)","volume":"10","author":"Nour","year":"2016","journal-title":"Front Hum Neurosci"},{"key":"10.1016\/j.eclinm.2024.102799_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/02698811221080165","article-title":"Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca","volume":"36","author":"Agin-Liebes","year":"2022","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.eclinm.2024.102799_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/02698811211066709","article-title":"Validation of the psychological insight scale: a new scale to assess psychological insight following a psychedelic experience","volume":"36","author":"Peill","year":"2022","journal-title":"J Psychopharmacol"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102799_bib27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/02698811231167848","article-title":"A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression","volume":"37","author":"Weiss","year":"2023","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.eclinm.2024.102799_bib28","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1192\/bjo.2022.565","article-title":"Effects of psilocybin versus escitalopram on rumination and thought suppression in depression","volume":"8","author":"Barba","year":"2022","journal-title":"BJPsych Open"},{"key":"10.1016\/j.eclinm.2024.102799_bib29","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1038\/s41598-023-49817-4","article-title":"Psychedelics and sexual functioning: a mixed-methods study","volume":"14","author":"Barba","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.eclinm.2024.102799_bib30","series-title":"Psilocybin for depression: the ACE model manual","author":"Watts","year":"2021"},{"key":"10.1016\/j.eclinm.2024.102799_bib31","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.eclinm.2024.102799_bib32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1192\/bjp.180.5.461","article-title":"The work and social adjustment scale: a simple measure of impairment in functioning","volume":"180","author":"Mundt","year":"2002","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.eclinm.2024.102799_bib33","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1007\/s00213-022-06187-5","article-title":"The watts connectedness scale: a new scale for measuring a sense of connectedness to self, others, and world","volume":"239","author":"Watts","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.eclinm.2024.102799_bib34","first-page":"247","article-title":"New measures of well-being: flourishing and positive and negative feelings","volume":"39","author":"Diener","year":"2010","journal-title":"Soc Indic Res"},{"key":"10.1016\/j.eclinm.2024.102799_bib35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1037\/0022-0167.53.1.80","article-title":"The meaning in life questionnaire: assessing the presence of and search for meaning in life","volume":"53","author":"Steger","year":"2006","journal-title":"J Counsel Psychol"},{"key":"10.1016\/j.eclinm.2024.102799_bib36","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S2212-5671(15)00123-9","article-title":"How reliable are measurement scales? External factors with indirect influence on reliability estimators","volume":"20","author":"Ursachi","year":"2015","journal-title":"Procedia Econ Finance"},{"key":"10.1016\/j.eclinm.2024.102799_bib37","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(02)07882-0","article-title":"Sample size slippages in randomised trials: exclusions and the lost and wayward","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2024.102799_bib38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Roy Stat Soc B"},{"key":"10.1016\/j.eclinm.2024.102799_bib39","article-title":"sgof: an R package for multiple testing problems","volume":"6","author":"Castro-Conde, I. & de U\u00f1a-\u00c1lvarez, J","year":"2014","journal-title":"R J"},{"key":"10.1016\/j.eclinm.2024.102799_bib40","series-title":"Statistical power analysis for the behavioural sciences","author":"Cohen","year":"2013"},{"key":"10.1016\/j.eclinm.2024.102799_bib41","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamapsychiatry.2022.2546","article-title":"Preparing for the bursting of the psychedelic hype bubble","volume":"79","author":"Yaden","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.eclinm.2024.102799_bib42","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/02698811211073759","article-title":"Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: prospective 12-month follow-up","volume":"36","author":"Gukasyan","year":"2022","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.eclinm.2024.102799_bib43","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.eclinm.2024.102799_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109398","article-title":"Canalization and plasticity in psychopathology","volume":"226","author":"Carhart-Harris","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eclinm.2024.102799_bib45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S2215-0366(23)00363-2","article-title":"Treatment with psychedelics is psychotherapy: beyond reductionism","volume":"11","author":"Gr\u00fcnder","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.eclinm.2024.102799_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115349","article-title":"Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: a systematic review and individual participant data meta-analysis","volume":"327","author":"Simonsson","year":"2023","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.eclinm.2024.102799_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jad.2014.06.043","article-title":"Relapse rates after psychotherapy for depression - stable long-term effects? A meta-analysis","volume":"168","author":"Steinert","year":"2014","journal-title":"J Affect Disord"},{"key":"10.1016\/j.eclinm.2024.102799_bib48","series-title":"Depression in adults: treatment and management","year":"2022"},{"key":"10.1016\/j.eclinm.2024.102799_bib49","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/wps.20701","article-title":"A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression","volume":"19","author":"Cuijpers","year":"2020","journal-title":"World Psychiatry"},{"key":"10.1016\/j.eclinm.2024.102799_bib50","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archpsyc.63.11.1217","article-title":"Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis","volume":"63","author":"Taylor","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.eclinm.2024.102799_bib51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev.psych.57.102904.190044","article-title":"Enduring effects for cognitive behaviour therapy in the treatment of depression and anxiety","volume":"57","author":"Hollon","year":"2006","journal-title":"Annu Rev Psychol"},{"key":"10.1016\/j.eclinm.2024.102799_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.118829","article-title":"Escitalopram modulates learning content-specific neuroplasticity of functional brain networks","volume":"247","author":"Kl\u00f6bl","year":"2022","journal-title":"Neuroimage"},{"key":"10.1016\/j.eclinm.2024.102799_bib53","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41398-022-02039-0","article-title":"Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study","volume":"12","author":"Cavanna","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.eclinm.2024.102799_bib54","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/02791072.2019.1593561","article-title":"Might microdosing psychedelics be safe and beneficial? An initial exploration","volume":"51","author":"Fadiman","year":"2019","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.eclinm.2024.102799_bib55","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62878","article-title":"Self-blinding citizen science to explore psychedelic microdosing","volume":"10","author":"Szigeti","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.eclinm.2024.102799_bib56","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.jad.2011.03.046","article-title":"Clinical effectiveness: the importance of psychosocial functioning outcomes","volume":"132","author":"Lam","year":"2011","journal-title":"J Affect Disord"},{"key":"10.1016\/j.eclinm.2024.102799_bib57","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.3389\/fpsyt.2022.1025726","article-title":"The economics of psychedelic-assisted therapies: a research agenda","volume":"13","author":"Marseille","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.eclinm.2024.102799_bib58","series-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"2015"},{"key":"10.1016\/j.eclinm.2024.102799_bib59","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neubiorev.2016.03.004","article-title":"Assessing anhedonia in depression: potentials and pitfalls","volume":"65","author":"Rizvi","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.eclinm.2024.102799_bib60","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-clinpsy-050212-185606","article-title":"Depression, stress, and anhedonia: toward a synthesis and integrated model","volume":"10","author":"Pizzagalli","year":"2014","journal-title":"Annu Rev Clin Psychol"},{"key":"10.1016\/j.eclinm.2024.102799_bib61","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3389\/fpsyt.2023.1134865","article-title":"Breaking the vicious cycle: the interplay between loneliness, metabolic illness, and mental health","volume":"14","author":"Ahmed","year":"2023","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.eclinm.2024.102799_bib62","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41572-022-00355-9","article-title":"Loneliness and health","volume":"8","author":"Hawkley","year":"2022","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.eclinm.2024.102799_bib63","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1176\/appi.ajp.163.1.148","article-title":"How should remission from depression be defined? The depressed patient's perspective","volume":"163","author":"Zimmerman","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eclinm.2024.102799_bib64","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jad.2014.12.004","article-title":"What is important in being cured from depression? Discordance between physicians and patients (1)","volume":"174","author":"Demyttenaere","year":"2015","journal-title":"J Affect Disord"},{"key":"10.1016\/j.eclinm.2024.102799_bib65","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","article-title":"Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic","volume":"398","author":"COVID-19 Mental Disorders Collaborators","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2024.102799_bib66","article-title":"Comparison of mental health symptoms before and during the covid-19 pandemic: evidence from a systematic review and meta-analysis of 134 cohorts","volume":"380","author":"Sun","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2024.102799_bib67","article-title":"Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression","author":"Wall","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.eclinm.2024.102799_bib68","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/02699930802607937","article-title":"Retrospective recall of affect in clinically depressed individuals and controls","volume":"23","author":"Ben-Zeev","year":"2009","journal-title":"Cognit Emot"},{"key":"10.1016\/j.eclinm.2024.102799_bib69","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/JMDH.S104807","article-title":"Information bias in health research: definition, pitfalls, and adjustment methods","volume":"9","author":"Althubaiti","year":"2016","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.eclinm.2024.102799_bib70","series-title":"Psychedelics, meaningfulness, and the \"Proper Scope\" of medicine: continuing the conversation","first-page":"1","author":"Cheung","year":"2023"},{"key":"10.1016\/j.eclinm.2024.102799_bib71","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1177\/0269881117725915","article-title":"Serotonin and brain function: a tale of two receptors","volume":"31","author":"Carhart-Harris","year":"2017","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.eclinm.2024.102799_bib72","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/0269881108094300","article-title":"Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later","volume":"22","author":"Griffiths","year":"2008","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.eclinm.2024.102799_bib73","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fphar.2017.00974","article-title":"Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression","volume":"8","author":"Roseman","year":"2017","journal-title":"Front Pharmacol"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702400378X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702400378X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T19:08:36Z","timestamp":1732043316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258953702400378X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":73,"alternative-id":["S258953702400378X"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102799","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102799"}}